Ecron Acunova CRO Expands its Clinical Research Center for Drug Development
Ecron Acunov announced expansion of their Mangalore Clinical Pharmacology Unit to a 80 bed facility. The Research Center was dedicated by Dr. Ramdas M Pai, Chancellor, Manipal University.
This expansion caters to the growing needs of its global clients in Pharmaco-Kinetic and Pharmaco Dynamic studies. This takes total bed capacity to 176 units in research centers at Mangalore, Manipal, and Bangalore. Drug research involves analyzing the activity of the drug in plasma using spectroscopy. Highly sophisticated spectrometers have been added. Speaking on the occasion Dr. Ramdas Pai said, "I commend the safe conduct of studies for Indian and global companies, leveraging the scientific and clinical talent of India. It is heartening to note that studies conducted at the center, got US FDA approval, leading to launch of drugs for treatment of HIV, cancer etc."
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
